Year |
Citation |
Score |
2016 |
Everson R, Shin N, Antonios J, Soto H, Tucker A, Zaretsky J, Orpilla J, Rathe S, Popescu F, Largaespada D, Liau L, Prins R. IMST-56. TUMOR LYSATE-PULSED DC VACCINATION INDUCES NEOANTIGEN-SPECIFIC T CELL RESPONSES Neuro-Oncology. 18: vi99-vi99. DOI: 10.1093/Neuonc/Now212.412 |
0.466 |
|
2011 |
Dings RP, Vang KB, Castermans K, Popescu F, Zhang Y, Oude Egbrink MG, Mescher MF, Farrar MA, Griffioen AW, Mayo KH. Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3134-45. PMID 21252159 DOI: 10.1158/1078-0432.Ccr-10-2443 |
0.624 |
|
2010 |
Olin MR, Andersen BM, Zellmer DM, Grogan PT, Popescu FE, Xiong Z, Forster CL, Seiler C, SantaCruz KS, Chen W, Blazar BR, Ohlfest JR. Superior efficacy of tumor cell vaccines grown in physiologic oxygen. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4800-8. PMID 20858839 DOI: 10.1158/1078-0432.Ccr-10-1572 |
0.327 |
|
2010 |
Fujita M, Decker SA, Popescu F, McDonald HA, Kohanbash G, Ohlfest JR, Okada H. Abstract 1359: COX2 blockade suppresses glioma-genesis by promoting anti-glioma immunosurveillance Cancer Research. 70: 1359-1359. DOI: 10.1158/1538-7445.Am10-1359 |
0.405 |
|
2007 |
Mescher MF, Popescu FE, Gerner M, Hammerbeck CD, Curtsinger JM. Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors. Seminars in Cancer Biology. 17: 299-308. PMID 17656106 DOI: 10.1016/J.Semcancer.2007.06.008 |
0.604 |
|
2006 |
Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z. Signals required for programming effector and memory development by CD8+ T cells. Immunological Reviews. 211: 81-92. PMID 16824119 DOI: 10.1111/J.0105-2896.2006.00382.X |
0.464 |
|
Show low-probability matches. |